Patna, Feb 7 (IANS) Bihar Chief Minister Jitan Ram Manjhi Saturday met his predecessor Nitish Kumar for a "patch up" as the crisis deepened in the ruling JD-U over his replacement.
"Manjhi visited Nitish Kumar's official residence to discuss some issues for patch up and to settle issues," a Janata Dal-United leader said.
Amid speculation that the JD-U is heading for a split, JD-U president Sharad Yadav invited both Manjhi and Nitish Kumar for a meeting together to end the crisis in the party, the JD-U leader said.
"It was made possible by Sharad Yadav, who has invited Manjhi and Nitish Kumar to meet for a patch up in the presence of him," he said.
Early Saturday, Manjhi called for a cabinet meeting ahead of the JD-U legislature party meeting called by Sharad Yadav this evening.
The chief minister also held close door meetings with his close associates including two ministers and some party legislators Saturday morning.
Nitish Kumar also held meetings with party leaders, including half a dozen ministers.
The gathering of farmers at the Shambhu border is continuously increasing. There are more youth a
This is very worrying news. In the country, 1.15 lakh new infections have been detected in a sing
The issue of PM Cares Fund has cropped up once again. This time a petition has been filed in this
According to the medical journal Lancet, it is being tested in China how effective anti-HIV drugs
Sri Lanka Protest: Nationwide strike against hike in tax rates in Sri Lanka, life disrupted
Sri Lankan trade unions called for a nationwide strike on Wednesday to protest against the hike i
Prime Minister Narendra Modi will be on a US tour from June 21. This tour is being given a lot of
Amid the Russia-Ukraine war, North Korea has spoken of recognizing the Donbas as a separate count
This time the country is expected to receive good rains from last time. The India Meteorological
Saradha Scam: Arrested Former Union Minister Hospitalised
Kolkata, Feb 1 (IANS) Former union minister Matang Sinh, arrested by the CBI for his alleged co
Trials of Covaxin are ongoing on children aged 2 to 18 years. Meanwhile, the hopes of getting ano